Predicted to enable CCR6 chemokine receptor binding activity and chemoattractant activity. Predicted to be involved in cell chemotaxis and defense response to bacterium. Predicted to be active in extracellular space. Orthologous to human DEFB109C (defensin beta 109C). [provided by Alliance of Genome Resources, Apr 2022]